Bengaluru, July 31, 2026 — If there is a single defining theme running through India's new-age technology IPO landscape in the middle months of 2026, it is retreat. One after another, some of the country's most closely watched consumer internet and fintech companies — companies that, only months earlier, had been actively preparing for public listings, filing draft prospectuses, and conducting institutional investor roadshows — have instead chosen to pause, defer or indefinitely shelve their IPO plans. Cloud kitchen operator Curefoods is only the latest name to join a list that already includes fintech giant PhonePe and e-commerce major Flipkart, and the pattern raises a genuinely important question for India's broader startup ecosystem: what changed?
Curefoods: the latest domino to fall
Curefoods, the Bengaluru-based cloud kitchen operator founded by former Flipkart executive Ankit Nagori, had appeared to be on a clear path toward a public listing after receiving approval from the Securities and Exchange Board of India (SEBI) for its draft red herring prospectus, filed in June of last year. The company had been targeting a roughly ₹800 crore fresh issue, alongside an offer-for-sale component from existing investors including Accel, Chiratae Ventures, Nordstar Partners, Iron Pillar and Alteria Capital, at a valuation of approximately ₹4,000 crore.
That plan has now been put on hold. According to people familiar with the process, Curefoods' institutional roadshows, conducted since the start of the year, failed to secure mutual fund alignment around the company's targeted valuation, with investors pushing back given prevailing market conditions and broader caution around loss-making new-age consumer businesses. Curefoods, which operates a multi-brand portfolio spanning cloud kitchen concepts including CakeZone, Frozen Bottle and Sharief Bhai, alongside the Indian franchise rights for Krispy Kreme, narrowed its net loss only marginally in the most recent fiscal year even as revenue grew at a healthy clip — a financial profile that, evidently, institutional investors were unwilling to underwrite at the company's preferred valuation given the current market environment for loss-making consumer internet businesses.
PhonePe: a bellwether name steps back
Curefoods' decision to defer follows a similar move by Walmart-backed PhonePe, one of India's largest digital payments companies, which postponed its planned $1.3 billion IPO earlier this year, citing volatile market conditions alongside a valuation gap with mutual fund investors broadly similar in character to the dynamic that would later confront Curefoods. PhonePe's decision carried particular significance given the company's scale and its status as one of the most closely watched names in India's fintech IPO pipeline, with many market participants viewing a successful PhonePe listing as an important signal for the broader health of investor appetite toward India's digital payments and fintech sector more broadly.
That PhonePe, despite its scale, its Walmart backing, and its dominant position in India's Unified Payments Interface (UPI) ecosystem, nonetheless chose to defer rather than push forward with a listing at a discounted valuation, sent a clear signal to the broader new-age IPO pipeline about just how selective and price-disciplined India's institutional investor base had become by the time PhonePe reached its own roadshow process.
Flipkart's indefinite pause
Perhaps the most striking name on this growing list is Flipkart itself, the e-commerce giant that indefinitely paused its own IPO discussions earlier this year, citing a combination of rising market volatility, a crowded pipeline of large competing public issues, and broader concerns around investor appetite for loss-making internet companies generally. Flipkart's decision carries outsized symbolic weight given the company's status as one of the original pioneers of India's e-commerce and broader startup ecosystem, dating back to its founding in the late 2000s — a company whose eventual public listing has been anticipated by market participants for years as one of the marquee events of India's new-age IPO cycle.
That even Flipkart, with its deep-pocketed Walmart ownership and its dominant e-commerce market position, chose to step back from its listing timeline rather than proceed amid current market conditions, underscores just how broadly the current wave of institutional caution has spread across India's new-age company IPO pipeline, extending well beyond any single sector or company-specific concern.
What's actually driving the pullback
Multiple factors appear to be converging to produce this broad-based wave of IPO deferrals. Chief among them is a persistent, structural valuation gap between what founders and existing venture investors — who typically anchor their valuation expectations to earlier private funding rounds conducted during more exuberant market conditions — believe their companies are worth, and what public market mutual fund investors, who must answer directly to retail unit-holders and apply more conservative, profitability-focused valuation discipline, are willing to pay in a public listing.
Beyond this valuation gap, several market participants have pointed to broader macro and geopolitical volatility as a contributing factor dampening near-term investor risk appetite for new IPOs generally, including specific references to instability linked to tensions in West Asia that have periodically rattled global capital markets through 2026, adding a layer of macro uncertainty on top of the more company-specific valuation disagreements driving individual IPO deferral decisions.
There is also a simple supply-side dynamic at play: with a genuinely crowded pipeline of large new-age companies simultaneously preparing for public listings, institutional investors have found themselves able to be considerably more selective about which specific opportunities they commit capital to, effectively creating a buyer's market in which companies without an unambiguously compelling profitability and growth story have found it increasingly difficult to secure the kind of anchor investor commitment needed to proceed confidently with a listing at their preferred valuation.
A regulatory safety valve
Interestingly, market regulator SEBI has itself provided a degree of structural flexibility that has made this wave of deferrals more manageable for affected companies than might otherwise have been the case. Under existing regulations, companies typically have a twelve-month window from the date of their final SEBI observation letter to launch their public issue, extended to eighteen months for companies that use the confidential pre-filing route. Recognising the current wave of deferrals, the regulator has established an extended cut-off window for observation letters set to expire between April and September 2026, automatically extending validity for affected companies until the end of September — a provision that gives companies like Curefoods genuine flexibility to wait for more favourable market conditions rather than being forced into a rushed, potentially poorly received listing simply to beat an approaching regulatory deadline.
Not every company is pulling back
It would be a mistake to read the current environment as a uniform retreat across India's entire new-age IPO pipeline. Even as Curefoods, PhonePe and Flipkart have each chosen to pause, other companies have continued pushing ahead with their own listing plans, suggesting the current environment reflects heightened investor selectivity rather than a wholesale collapse in appetite for new-age Indian IPOs. Housing finance company TruHome Finance has secured SEBI approval for its own public issue, while OYO's parent entity Prism has similarly received regulatory clearance for a substantial IPO of its own. Data cited in recent market coverage suggests more than 160 companies collectively hold approval to raise in excess of ₹1.6 lakh crore through public issues, indicating that the overall IPO pipeline, while facing near-term execution delays for some of its highest-profile names, remains substantial in aggregate scale.
What this means for the broader startup ecosystem
For India's broader startup and venture capital ecosystem, this wave of high-profile IPO deferrals carries meaningful implications that extend well beyond the specific companies involved. Venture and growth-equity investors who had been counting on near-term public listings to provide liquidity events for their existing portfolio positions now face extended holding periods, potentially affecting overall fund return timelines and, by extension, the pace at which those funds can raise and deploy fresh capital into new investment opportunities. Founders across the broader startup ecosystem, meanwhile, are likely absorbing a clear signal from this wave of deferrals: public market investors have grown considerably more disciplined about demanding credible, near-term profitability visibility before committing capital, a bar that companies still operating with significant losses, however strong their revenue growth or market position, may struggle to clear without either accepting a meaningfully discounted valuation or investing additional time in demonstrating improved unit economics before attempting their own eventual public listing.
Looking ahead
As India's IPO market navigates this period of heightened selectivity, the key question for market participants is whether the current wave of deferrals represents a temporary pause — driven by specific, potentially transient factors including global geopolitical volatility and a temporarily crowded issuance pipeline — or a more durable structural shift in how India's institutional investor base evaluates new-age, loss-making consumer and fintech businesses going forward. The answer will likely become clearer over the coming several months, as companies including Curefoods, PhonePe and Flipkart each individually decide when and under what valuation terms to eventually return to the public markets, and as the broader pipeline of more than 160 approved-but-not-yet-listed companies gradually works its way through India's primary market over the remainder of 2026 and into 2027.
The founders' dilemma: wait it out or reprice
For founders of companies currently sitting on SEBI-approved but unexercised IPO windows, the current environment presents a genuinely difficult strategic choice. Waiting for more favourable market conditions preserves the possibility of eventually achieving a valuation closer to what earlier private funding rounds implied, but carries its own risks: continued cash burn during the waiting period, the possibility that market conditions fail to improve meaningfully within the extended regulatory window, and the reputational cost of a prolonged, publicly visible IPO delay that can itself become a negative signal to customers, employees and prospective future investors. Alternatively, proceeding with a listing at a discounted valuation, closer to what institutional investors are actually willing to pay, crystallises a lower valuation outcome but provides both the capital and public-market currency that a successful listing, even at reduced terms, can offer.
Different companies within the current wave of deferrals appear to be approaching this dilemma differently. Some, like Curefoods, have signalled an intention to relist within the coming year once conditions improve, suggesting a wait-and-see approach. Others within the broader pipeline may ultimately conclude that proceeding at a lower valuation, while painful, offers a more prudent path than an open-ended wait for market conditions that may not meaningfully improve within any predictable timeframe.
What institutional investors are telling bankers
Conversations with investment bankers active across India's IPO advisory market suggest a fairly consistent message being communicated to prospective issuers during this period: institutional investors are not closed to new-age company listings altogether, but are applying meaningfully more rigorous scrutiny to unit economics, path-to-profitability timelines, and overall capital efficiency than was typical during the more exuberant IPO market conditions of 2021 and even much of 2024. Bankers report that companies able to present a genuinely credible, well-substantiated profitability narrative — rather than pure growth-at-scale positioning — have continued to find meaningful institutional interest even within the current more selective environment, suggesting the issue is less a blanket closure of the new-age IPO window and more a recalibration of what qualifies as an attractive investment opportunity within that window.
The employee equity angle
An often-overlooked dimension of the current IPO deferral wave concerns the thousands of employees at Curefoods, PhonePe and Flipkart who hold stock options or other equity compensation tied to an eventual public listing. For these employees, prolonged IPO delays translate directly into extended illiquidity for what is, in many cases, a meaningful component of their overall compensation, particularly for early and mid-career employees who joined these companies during their earlier growth phases partly on the strength of promised equity upside. Companies navigating extended IPO delays have, in various instances, sought to address this employee liquidity concern through secondary share sale programmes or extended option exercise windows, even as these measures typically provide only partial mitigation compared to the liquidity a genuine public listing would eventually unlock.
